TABLE 7

Reported Sensitivity, Specificity, Accuracy, and Proportion of Primary Tumor Detection

StudyYearStudy typen*Results
Type I/IIType A/BTPFPTNFNSSpAcc% PD
Rege et al. (5)1994IIB420201.001.001.0050.00
Schipper et al. (11)1996IA1643901.000.750.8125.00
Kole et al. (16)1998IA29701930.701.000.9024.14
Shinohara et al. (10)1999IA420110.671.000.7550.00
Hanasono et al. (13)1999IIA2074630.700.600.6535.00
Greven et al. (15)1999IIB1316510.500.450.467.69
Lassen et al. (8)1999IA2094520.820.560.7045.00
Safa et al. (14)1999IA1431910.750.900.8621.43
Gupta et al. (12)1999IIA31200920.911.000.9364.52
Aassar et al. (35)1999IIB1793501.000.620.8252.94
Lonneux and Reffad (7)2000IA24136501.000.450.7554.17
Trampal et al. (9)2000IA941401.000.800.8944.44
Bohuslavizki et al. (6)2000IA522062240.830.790.8138.46
Jungehülsing et al. (36)2000IB27701820.781.000.9325.93
Cheng et al. (34)2000IIB1894501.000.560.7850.00
  • * No. of patients included in meta-analysis (after excluding patients without confirmation of 18F-FDG PET study).

  • Proportion of UPT patients in which 18F-FDG PET correctly detects primary tumor, presented in percentage.

  • Type I = 18F-FDG PET was performed when all diagnostic procedures carried out did not detect primary tumor; Type II = 18F-FDG PET was compared with CT or MRI after negative results in conventional diagnostic procedures; Type A = whole-body 18F-FDG PET study was carried out; Type B = 18F-FDG PET study only included head-neck-thorax region; TP = true-positive; FP = false-positive; TN = true-negative; FN = false-negative; S = sensitivity; Sp = specificity; Acc = diagnostic accuracy.